School Of Medicine Faculty

The Vanderbilt Kennedy Center has announced its latest Nicholas Hobbs Discovery Awards, which recognize innovative research to improve the lives of people with intellectual and developmental disabilities. Colleen Niswender, Dr. Bill Nobis, Audrey Bowden and Laurie Cutting are the recipients for 2025–26, earning support for projects that address Rett syndrome, Dravet syndrome and other developmental epilepsies, and reading difficulties like dyslexia. Read More

Schizophrenia has been proven to be heritable, but typical analyses so far haven’t been able to pinpoint what, genetically, is going wrong in the brain. A new paper by Professor Bingshan Li and research instructor Rui Chen outlines how to improve on existing genetic screening for schizophrenia risk by expanding the areas of the chromosome scanned for genetic signals. Their results point to a “tangible biological pathway—and potential treatment target—linking genetic risk to the pathogenesis of schizophrenia,” Chen said. Read More

Vanderbilt has announced eleven awardees in the latest round of its Innovation Catalyst Fund, an initiative that supports translational research that has promising commercial potential. Read More

In this episode of Quantum Potential, Craig Lindsley, William K. Warren, Jr. Professor of Medicine, University Distinguished Professor of Biochemistry, Chemistry and Pharmacology and executive director of the Warren Center for Neuroscience Drug Discovery, joins Provost C. Cybele Raver to discuss transformative research exploring how subtle tweaks to brain chemistry could change the way we treat neurodegenerative diseases and chronic pain. Read More

The trial, which is funded by a K23 Career Development Award from the National Institute of Diabetes and Digestive and Kidney Diseases, is expected to begin this summer and will assign peer-parent coaches to families to determine whether their having support to navigate the medical system and other challenges means their children will be healthier.   Read More

Crucial research by Neil Osheroff and his lab leads to approval of the first new class of antibacterial drugs in decades. The drug, gepotidacin, developed by GlaxoSmithKline under the brand name Blujepa, will be available starting later this year, potentially bringing relief to thousands of women who struggle with uncomplicated urinary tract infections. Read More

What does the way we learn have to do with drug addiction? In our fourth episode, Erin Calipari, associate professor of pharmacology and director of the Vanderbilt Center for Addiction Research, joins Provost C. Cybele Raver for an enlightening conversation. In this episode, they discuss nucleus accumbens—the part of our brain that helps us link cues and outcomes—and dissect how it affects the ways we make decisions that can lead to addictions, from food or drugs to behaviors. Read More

Medicine often takes a one-size-fits-all approach, but a disorder’s root cause can vary. Vanderbilt researchers have found that, for people with long QT syndrome, a heart condition that causes an irregular heartbeat, a more tailored approach could be beneficial. The research, led by Vanderbilt University Professor of Biochemistry and Vice Dean of Basic Sciences Charles Sanders and Northwestern University Professor and Chair of Pharmacology Dr. Al George, was published in PNAS in February 2025. Read More

Peter Embí, professor and chair of the Department of Biomedical Informatics, is among 100 newly elected members of the National Academy of Medicine, the organization announced this week. Read More

Erin Calipari, director of the Vanderbilt Center for Addiction Research and associate professor of pharmacology and molecular physiology and biophysics, has been recognized with the Society for Neuroscience’s 2024 Jacob P. Waletzky award. Read More

Thirteen outstanding faculty members from across the university have been selected for the 2024 cohort of Chancellor Faculty Fellows. This group is composed of highly accomplished, recently tenured faculty from a wide variety of disciplines and areas of expertise.    Read More

Six faculty have been appointed as residential leaders in shaping student learning experiences beyond the classroom. Dean of Residential Colleges and Residential Education Melissa Gresalfi announced the appointments for the 2024–25 academic year. Read More

Sixty-six faculty members across seven schools and colleges received Provost’s Faculty Grants for Culminating Projects in Immersion, up 50 percent from the program’s inaugural year in 2023. The goal of the grants is to empower undergraduate students through immersive and impactful learning opportunities that take them from the studio to the lab, to an internship, to service learning in the Nashville community and beyond. Read More

Jennifer Pietenpol, Ingram Professor of Cancer Research and professor of biochemistry, is the 2024 recipient of the Science of Oncology Award, which is presented annually to an individual who has made outstanding contributions to basic or translational research in cancer. Read More

The distinguished faculty members and deans representing eight colleges and schools were presented with medallions that symbolize the attainment of their positions and will become part of their official academic regalia. Chair holders contribute their expertise to real-world challenges, including climate change, political inequality and access to justice, artificial intelligence and ICU trauma.   Read More

Kimryn Rathmell, MD, PhD, MMHC, Hugh Jackson Professor of Medicine and chair of the Department of Medicine at Vanderbilt University Medical Center, will be appointed director of the National Cancer Institute. Through this upcoming appointment, Rathmell will become the NCI’s 17th director and only the second woman to hold this position leading the nation’s fight against cancer. She was chosen to serve in this role by President Biden. Read More